BioBytes: What are biosimilars?

Type:

Video

Biosimilars, also known as follow-on biologics, may eventually expand access and provide patients a more affordable alternative to innovative, lifesaving medicines. However, there are a few important safeguards that must be put into place before these similar but not the same versions of biologics can be safely introduced to the public. Join Dr. Targan as he explains the complex nature of biologics and the steps that need to be taken by Congress and the FDA to ensure that biosimilars are safe and effective while ensuring the continued development of cutting-edge medicines.

September 12, 2011 2012 World Congress on Industrial Biotechnology and Bioprocessing	September 12, 2011 Podcast: Margaret Anderson, Executive Director of FasterCures	September 9, 2011 Contagion: How Would We Respond to a Pandemic?	September 9, 2011 Eva Jack, Chief Business Officer at Pulmatrix, on the Promise of Biotech
August 15, 2011 Dr. Steven Perrin, CEO, CSO and Vice Chairman, ALS Therapy Development Institute	August 11, 2011 When RARE is not so RARE!	June 30, 2011 2012 Flash Mob Event - 2011 BIO International Convention	June 30, 2011 Humanitarian Award Winner Dr. Paul Offit